Clinical Trial Update: A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ACT-709478 in patients with photosensitive epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photosensitive Epilepsy

Drugs mentioned

• ACT-709478

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Photosensitive Epilepsy | Phase 2 | Status: COMPLETED